This study found controversial effects of EZH2 expression in MCC, meaning that higher EZH2 expression was associated with metastasis or recurrence, whereas low EZH2 expression correlated with shorter overall survival [49]. The gene discussed is EZH2; the disease is Merkel cell skin cancer.